Cargando…

Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms

Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in alpha-L-iduronidase (IDUA) which is involved in the degradation of dermatan and heparan sulfates. The disease has severe and milder phenotypic subtypes. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chkioua, Latifa, Khedhiri, Souhir, Kassab, Asma, Bibi, Amina, Ferchichi, Salima, Froissart, Roseline, Vianey-Saban, Christine, Laradi, Sandrine, Miled, Abdelhedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110106/
https://www.ncbi.nlm.nih.gov/pubmed/21521498
http://dx.doi.org/10.1186/1746-1596-6-39
_version_ 1782205480979922944
author Chkioua, Latifa
Khedhiri, Souhir
Kassab, Asma
Bibi, Amina
Ferchichi, Salima
Froissart, Roseline
Vianey-Saban, Christine
Laradi, Sandrine
Miled, Abdelhedi
author_facet Chkioua, Latifa
Khedhiri, Souhir
Kassab, Asma
Bibi, Amina
Ferchichi, Salima
Froissart, Roseline
Vianey-Saban, Christine
Laradi, Sandrine
Miled, Abdelhedi
author_sort Chkioua, Latifa
collection PubMed
description Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in alpha-L-iduronidase (IDUA) which is involved in the degradation of dermatan and heparan sulfates. The disease has severe and milder phenotypic subtypes. The aim of this study was the detection of mutations in the IDUA gene from 12 additional MPS I patients with various clinical phenotypes (severe, 8 cases; intermediate, 3 cases; mild, 1 case). PATIENTS AND METHODS: In this study, the IDUA mutations in eight unrelated Tunisian families were performed by amplifying and sequencing the IDUA exons and intron-exon jonctions. RESULTS: Five IDUA mutations were detected: one is the L578Q, a novel mutation found, in milder patient. The others were the previously described: P533R, Y581X, F602X and R628X that produce a severe and intermediate phenotype. In addition, eighteen variants, including eight previously unreported polymorphisms (IVS6+21c > a, IVS7+79c > t, IVS7-45 g > c, IVS9+36t > c, IVS10+140c > a, IVS11+33c > t, IVS12+13c > t and IVS12-31c > g), were detected. CONCLUSION: This paper, showed a heterogeneous pattern of mutations and polymorphisms among Tunisian patients.
format Online
Article
Text
id pubmed-3110106
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31101062011-06-08 Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms Chkioua, Latifa Khedhiri, Souhir Kassab, Asma Bibi, Amina Ferchichi, Salima Froissart, Roseline Vianey-Saban, Christine Laradi, Sandrine Miled, Abdelhedi Diagn Pathol Research Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a genetic defect in alpha-L-iduronidase (IDUA) which is involved in the degradation of dermatan and heparan sulfates. The disease has severe and milder phenotypic subtypes. The aim of this study was the detection of mutations in the IDUA gene from 12 additional MPS I patients with various clinical phenotypes (severe, 8 cases; intermediate, 3 cases; mild, 1 case). PATIENTS AND METHODS: In this study, the IDUA mutations in eight unrelated Tunisian families were performed by amplifying and sequencing the IDUA exons and intron-exon jonctions. RESULTS: Five IDUA mutations were detected: one is the L578Q, a novel mutation found, in milder patient. The others were the previously described: P533R, Y581X, F602X and R628X that produce a severe and intermediate phenotype. In addition, eighteen variants, including eight previously unreported polymorphisms (IVS6+21c > a, IVS7+79c > t, IVS7-45 g > c, IVS9+36t > c, IVS10+140c > a, IVS11+33c > t, IVS12+13c > t and IVS12-31c > g), were detected. CONCLUSION: This paper, showed a heterogeneous pattern of mutations and polymorphisms among Tunisian patients. BioMed Central 2011-04-26 /pmc/articles/PMC3110106/ /pubmed/21521498 http://dx.doi.org/10.1186/1746-1596-6-39 Text en Copyright ©2011 Latifa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chkioua, Latifa
Khedhiri, Souhir
Kassab, Asma
Bibi, Amina
Ferchichi, Salima
Froissart, Roseline
Vianey-Saban, Christine
Laradi, Sandrine
Miled, Abdelhedi
Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title_full Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title_fullStr Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title_full_unstemmed Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title_short Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
title_sort molecular analysis of mucopolysaccharidosis type i in tunisia: identification of novel mutation and eight novel polymorphisms
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110106/
https://www.ncbi.nlm.nih.gov/pubmed/21521498
http://dx.doi.org/10.1186/1746-1596-6-39
work_keys_str_mv AT chkioualatifa molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT khedhirisouhir molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT kassabasma molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT bibiamina molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT ferchichisalima molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT froissartroseline molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT vianeysabanchristine molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT laradisandrine molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms
AT miledabdelhedi molecularanalysisofmucopolysaccharidosistypeiintunisiaidentificationofnovelmutationandeightnovelpolymorphisms